MARKET

HTGM

HTGM

HTG Molecular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.50
+0.51
+8.51%
Opening 12:37 03/03 EST
OPEN
6.00
PREV CLOSE
5.99
HIGH
6.59
LOW
5.98
VOLUME
123.77K
TURNOVER
--
52 WEEK HIGH
13.80
52 WEEK LOW
3.780
MARKET CAP
30.81M
P/E (TTM)
-1.3755
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
HTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG EdgeSeq Technology
GlobeNewswire · 5d ago
Global Genetic Testing Market Size 2021, by Application, Type, Method: Covid 19 Impact Outlook, Growth Prospects and Forecast-2026
Feb 24, 2021 (The Expresswire) -- Global Genetic Testing Market is valued at 12.83 USD Billion in 2019 and expected to reach USD 29.59 Billion by 2026 with...
The Express Wire · 02/24 16:39
Global NGS-Based Monitoring and Diagnostic Test Market 2020 Objectives of the Study, Research Methodology and Assumptions, Value Chain Analysis and Forecast by 2025
CDN Newswire · 02/24 16:06
Cancer (Tumor) Profiling Market Size, Growth, Share 2021, Current Industry Status With Global Opportunities Top Key Players Target Audience and Forecast to 2024
Feb 22, 2021 (The Expresswire) -- Global Cancer (Tumor) Profiling Market Report 2021 -2024 contains systematic and point to point information regarding...
The Express Wire · 02/22 05:16
Genetic Testing Market : Analysis and In-depth Study on Size Trends, Emerging Growth Factors and Regional Forecast | ARC
Comserve · 02/19 14:18
Cancer or Tumor Profiling Market Share 2021 – Global Growth, Size, Trends, Industry Analysis, Key Players and Forecast 2021 – 2025
Feb 18, 2021 (The Expresswire) -- Global Cancer or Tumor Profiling Market Research report discusses the market growth drivers and challenges that the...
The Express Wire · 02/18 06:29
Cancer Profiling Market Size 2021 to 2025, Capacity, Production and Consumption Professional Analysis with Impact of COVID-19 on Industry
Feb 11, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Cancer Profiling Market” has...
The Express Wire · 02/11 07:22
Diagnosis of Autoimmune Diseases Market Size Report 2021 by Manufacturer Share, Price, Revenue, Gross Profit and Forecast to 2025
Feb 10, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Diagnosis of Autoimmune Diseases Market”...
The Express Wire · 02/10 08:58
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HTGM. Analyze the recent business situations of HTG Molecular through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average HTGM stock price target is 12.75 with a high estimate of 15.00 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 71
Institutional Holdings: 6.78M
% Owned: 143.02%
Shares Outstanding: 4.74M
TypeInstitutionsShares
Increased
5
381.14K
New
20
197.14K
Decreased
11
81.29K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-2.08%
Healthcare Equipment & Supplies
-1.87%
Key Executives
President/Chief Executive Officer/Director
John Lubniewski
Chief Financial Officer/Senior Vice President/Treasurer/Secretary
Shaun McMeans
Senior Vice President
Byron Lawson
Lead Director/Independent Director
Ann Hanham
Independent Director
Harry George
Independent Director
Michelle Griffin
Independent Director
Donnie Hardison
Independent Director
James LaFrance
Independent Director
Lee McCracken
  • Dividends
  • Splits
  • Insider Activity
No Data
About HTGM
HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.

Webull offers kinds of HTG Molecular Diagnostics Inc stock information, including NASDAQ:HTGM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HTGM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HTGM stock methods without spending real money on the virtual paper trading platform.